FDA
approval
· 2017-12-08
FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for Emtricitabine and Tenofovir Disoproxil Fumarate by Teva Pharmaceuticals, likely updating labeling or other aspects o…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)